Medicare 发表于 2025-3-23 12:51:10

Submitted on: 15 January 2007.
Revised on: 12 May 2007.
Accepted on: 19 June 2007.

___________________GYNECOLOGICAL ENDOCRINOLOGY---TAYLOR & FRANCIS LTD

Aerate 发表于 2025-3-23 14:41:57

Submitted on: 06 February 2014.
Revised on: 05 March 2014.
Accepted on: 29 April 2014.

___________________GYNECOLOGICAL ENDOCRINOLOGY---TAYLOR & FRANCIS LTD

FLIT 发表于 2025-3-23 21:10:29

http://reply.papertrans.cn/2/110/10998/10998-13.png

micronized 发表于 2025-3-24 00:37:05

Submitted on: 18 June 2012.
Revised on: 16 August 2012.
Accepted on: 25 September 2012.

___________________GYNECOLOGICAL ENDOCRINOLOGY---TAYLOR & FRANCIS LTD

Adulate 发表于 2025-3-24 03:09:45

http://reply.papertrans.cn/2/110/10998/10998-15.png

能得到 发表于 2025-3-24 07:12:21

http://reply.papertrans.cn/2/110/10998/10998-16.png

代理人 发表于 2025-3-24 11:20:59

http://reply.papertrans.cn/2/110/10998/10998-17.png

antedate 发表于 2025-3-24 15:12:11

Submitted on: 22 November 2008.
Revised on: 22 February 2009.
Accepted on: 13 April 2009.

___________________GYNECOLOGICAL ENDOCRINOLOGY---TAYLOR & FRANCIS LTD

发表于 2025-3-24 20:41:36

http://reply.papertrans.cn/2/110/10998/10998-19.png

出价 发表于 2025-3-25 02:30:07

http://reply.papertrans.cn/2/110/10998/10998-20.png
页: 1 [2] 3 4
查看完整版本: SCIE期刊GYNECOLOGICAL ENDOCRINOLOGY 2024/2025影响因子:2.185 (GYNECOL ENDOCRINOL) (0951-3590). (OBSTETRICS & GYNECOLOGY)(妇产科)S